UBS Maintains a 'Buy' on Actuant (ATU); Raising Number on Recent Positive Data
Tweet
Share
E-mailGet Alerts ATU Hot Sheet
Price: $21.87 --0%
Rating Summary:
1 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
1 Buy, 12 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
UBS maintains a 'Buy' on Actuant (NYSE: ATU) price target raised from $26 to $31.
UBS analyst says, "We no longer factor a US recession scenario into our target prices given improving US macro data and recent Euro area leading indicators that have surprised to the upside. Admittedly, there’s an element of marking to market in our action. We’re also making modest estimate updates and re-visiting valuation more broadly...With shares at a low 7.0x our NTM EBITDA (L5Y range 6-10x) and our view the fundamental outlook is tracking better, we remain constructive on ATU shares."
UBS slightly raises FY12/13 EPS from $1.96/2.19 to $2.00/2.20.
For an analyst ratings summary and ratings history on Actuant click here. For more ratings news on Actuant click here.
Shares of Actuant closed at $27.33 yesterday.
UBS analyst says, "We no longer factor a US recession scenario into our target prices given improving US macro data and recent Euro area leading indicators that have surprised to the upside. Admittedly, there’s an element of marking to market in our action. We’re also making modest estimate updates and re-visiting valuation more broadly...With shares at a low 7.0x our NTM EBITDA (L5Y range 6-10x) and our view the fundamental outlook is tracking better, we remain constructive on ATU shares."
UBS slightly raises FY12/13 EPS from $1.96/2.19 to $2.00/2.20.
For an analyst ratings summary and ratings history on Actuant click here. For more ratings news on Actuant click here.
Shares of Actuant closed at $27.33 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility
- SentinelOne Inc (S) PT Raised to $26 at Cantor Fitzgerald Following Strong Q2 Checks
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
